Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.

What you'll get out of this episode:

• Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
• The company’s patented technology improves absorption via buccal and GI routes.
• First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
• Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
• Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/